Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance

2025 ICD-10-CM code A03.3

Shigellosis due to Shigella sonnei (Group D shigellosis)

Use additional code to identify resistance to antimicrobial drugs (Z16.-). Shigellosis should be excluded from infectious and parasitic diseases complicating pregnancy, childbirth, and the puerperium (O98.-), as well as those specific to the perinatal period (P35-P39), and influenza and other acute respiratory infections (J00-J22).

Medical necessity for treatment is based on the presence of signs and symptoms of shigellosis, confirmation of infection through laboratory tests, and assessment of the severity of the illness to determine the need for rehydration and antibiotic therapies.

Clinicians should consider the diagnosis of shigellosis when evaluating patients presenting with symptoms such as diarrhea, abdominal pain, fever, and tenesmus, especially in the context of possible exposure to contaminated food or water sources. Diagnostic testing, particularly stool culture, is crucial for confirming infection and guiding appropriate treatment, which includes rehydration therapies and antibiotics in severe cases.

In simple words: Shigellosis, commonly known as Group D shigellosis, is an infection of the digestive system caused by the Shigella sonnei bacteria. This bacteria is often spread through contaminated food or water. Symptoms include diarrhea (sometimes bloody), stomach cramps, pain when passing stool, and fever. Severe cases can lead to dehydration, and children may experience seizures. Diagnosis involves stool tests, and treatment typically focuses on rehydration and, if necessary, antibiotics.

Shigellosis, an infection affecting the gastrointestinal system, is primarily caused by the bacterium Shigella sonnei, often transmitted through the consumption of water and food items contaminated with fecal matter.The infection typically manifests as watery or bloody diarrhea, accompanied by stomach pain, tenesmus (rectal pain during straining for bowel movements), and fever. In severe instances, patients can suffer from extreme dehydration, while seizures are a potential complication, particularly in children. Diagnosis involves laboratory tests on fecal samples to isolate the bacterium; if positive, a culture and sensitivity assessment may be performed to guide effective antibiotic selection. Treatment includes oral or intravenous rehydration and, in cases of severe infection, targeted antibiotic therapy. Shigella sonnei is the most commonly reported Shigella species in the U.S.

Example 1: A 3-year-old child presents with bloody diarrhea, fever, and abdominal pain after attending a picnic. Stool culture confirms Shigella sonnei, and the child receives intravenous rehydration and antibiotics., A traveler returning from a developing country develops persistent watery diarrhea and fever. A stool sample is positive for Shigella sonnei, prompting oral rehydration therapy and antibiotic treatment., An outbreak of shigellosis occurs in a community due to contaminated water supply. Several individuals present with various gastrointestinal symptoms, and A03.3 is used for coding the Shigella sonnei infections confirmed by laboratory testing.

Documentation should include signs and symptoms, travel history, exposure to potential sources of infection, laboratory results (stool culture and sensitivity), and treatment provided (rehydration, antibiotics).

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.